| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3107 | |||||||||||||||||||||||
| Submitter : | Mrs. Joyce Langmeier | Date & Time: | 12/14/2006 01:12:05 | |||||||||||||||||||||
| Organization : | Mrs. Joyce Langmeier | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I do not want you to use aborted fetal tissue or embryonic stem cells for vaccine production. Thank you. | ||||||||||||||||||||||||